Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.183490711679245e-36,45.41963916815865,3729.503702346472,"['RPL30', 'RPL34', 'RPLP1', 'RPL11', 'RPL10A', 'RPL9', 'RPS15', 'RPS14', 'RPS15A', 'RPL18A', 'RPL35', 'RPL38', 'RPS27A', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPL41', 'RPL21', 'RPS8', 'RPL35A', 'RPS3A', 'RPS26', 'RPS28', 'RPS27', 'RPS29', 'RPL24', 'RPL26', 'FAU', 'RPL29', 'RPS21', 'RPS24']",1.7031227551098112e-34,0,0,32
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.237108683285374e-28,36.03846153846154,2263.8140928665525,"['COX7B', 'UQCRB', 'COX4I1', 'COX17', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'ATP5MC1', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'COX8A', 'NDUFA7', 'ATP5PD', 'NDUFA5', 'NDUFA1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6']",2.042472386481296e-26,0,0,26
3,Nonalcoholic fatty liver disease WP4396,2.322982428332447e-18,17.269739356416725,701.2149667870706,"['COX8A', 'NDUFA13', 'COX7B', 'NDUFA7', 'UQCRB', 'NDUFA5', 'COX4I1', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'UQCRH', 'COX6B1', 'UQCRQ', 'NDUFS6', 'CYCS', 'UQCRFS1']",6.039754313664363e-17,0,0,22
4,Mitochondrial CIV Assembly WP4922,1.9809808597134026e-11,32.5125786163522,801.2674253455777,"['COX8A', 'COX7B', 'COX4I1', 'COX17', 'COX7A2', 'COX14', 'COX5B', 'COX6C', 'PET117', 'COX6B1']",3.862912676441135e-10,0,0,10
5,Oxidative phosphorylation WP623,2.6992866434097762e-09,17.545469998300188,346.17700605830197,"['NDUFA7', 'ATP5PD', 'NDUFA5', 'NDUFS6', 'NDUFB2', 'NDUFB1', 'ATP5MG', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",4.210887163719251e-08,0,0,10
6,Mitochondrial complex III assembly WP4921,2.447553113592825e-08,54.4364592462752,954.0311718225821,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",3.1818190476706725e-07,0,0,6
7,Mitochondrial complex I assembly model OXPHOS system WP4324,3.4430818983702e-06,13.121822803195352,165.06129316416423,"['NDUFA13', 'NDUFA7', 'NDUFA5', 'NDUFS6', 'NDUFB2', 'NDUFA1', 'NDUFB1']",3.8365769724696514e-05,0,0,7
8,Proteasome Degradation WP183,0.02774073752263492,4.90852885225111,17.596355743576616,"['PSMB6', 'H2AFZ', 'PSMB10']",0.27047219084569046,0,0,3
9,Fatty acid beta-oxidation WP143,0.04405947397307,6.517491333123227,20.349008398104885,"['ECI1', 'LPL']",0.3818487744332733,0,0,2
10,Alzheimer's disease WP2059,0.0506767177396438,3.802557167445291,11.340323233693642,"['ATP5MD', 'LPL', 'CYCS']",0.39527839836922163,0,0,3
11,Copper homeostasis WP3286,0.06038974758282232,5.381931788596719,15.106737712672366,"['COX17', 'ATOX1']",0.4074757721140251,0,0,2
12,Composition of Lipid Particles WP3601,0.06268858032523462,20.547619047619047,56.90819215852896,['LPL'],0.4074757721140251,0,0,1
13,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0777403969465779,15.40922619047619,39.36102301009096,['COX8A'],0.4664423816794674,0,0,1
14,Eukaryotic Transcription Initiation WP405,0.0929182090996304,4.123353293413174,9.797234401411119,"['POLR2I', 'POLR2K']",0.5176871649836551,0,0,2
15,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.10712694469987656,10.270833333333334,22.94237893947704,['LPL'],0.5570601124393582,0,0,1
16,7q11.23 copy number variation syndrome WP4932,0.11932158731719332,2.582078313253012,5.489325537067192,"['VPS37B', 'ATP5F1E', 'ATP5MC1']",0.5783926351665779,0,0,3
17,Selenium Micronutrient Network WP15,0.134712518296553,3.252757642609518,6.520517866227957,"['SELENOW', 'SELENOH']",0.5783926351665779,0,0,2
18,Genotoxicity pathway WP4286,0.134712518296553,3.252757642609518,6.520517866227957,"['PLK3', 'RPS27']",0.5783926351665779,0,0,2
19,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.1494703544048275,6.845238095238095,13.010451099566406,['ECI1'],0.5783926351665779,0,0,1
20,Kallmann's Syndrome WP5074,0.16313638427775273,6.160119047619047,11.169335135751219,['ANOS1'],0.5783926351665779,0,0,1
21,TP53 network WP1742,0.16313638427775273,6.160119047619047,11.169335135751219,['SUMO1'],0.5783926351665779,0,0,1
22,Triacylglyceride synthesis WP325,0.16313638427775273,6.160119047619047,11.169335135751219,['LPL'],0.5783926351665779,0,0,1
23,Nanomaterial induced apoptosis WP2507,0.1765841116640413,5.5995670995671,9.70941396045403,['CYCS'],0.5859778047386225,0,0,1
24,Statin inhibition of cholesterol production WP430,0.18981700321025988,5.132440476190476,8.528549711869426,['LPL'],0.5859778047386225,0,0,1
25,Ciliary landscape WP4352,0.19427772676901592,1.7955204216073781,2.9419001728575807,"['NDUFA5', 'MFAP1', 'MYL6B', 'COX6C']",0.5859778047386225,0,0,4
26,Apoptosis Modulation by HSP70 WP384,0.20283847087106163,4.737179487179487,7.55743715651783,['CYCS'],0.5859778047386225,0,0,1
27,MTHFR deficiency WP4288,0.20283847087106163,4.737179487179487,7.55743715651783,['CYCS'],0.5859778047386225,0,0,1
28,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.22826051384258217,4.104761904761904,6.063832168780537,['H2AFZ'],0.6139420717145314,0,0,1
29,Canonical and non-canonical Notch signaling WP3845,0.22826051384258217,4.104761904761904,6.063832168780537,['MFAP1'],0.6139420717145314,0,0,1
30,Monoamine GPCRs WP58,0.2528764742472416,3.6211484593837535,4.978551000065114,['HRH1'],0.6153604688481805,0,0,1
31,Androgen receptor signaling pathway WP138,0.2564773765036005,2.0907337866639604,2.8448924461539162,"['SUMO1', 'BAG1']",0.6153604688481805,0,0,2
32,Pyrimidine metabolism WP4022,0.262447193237477,2.055688622754491,2.74990574220027,"['POLR2I', 'POLR2K']",0.6153604688481805,0,0,2
33,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2648901460191304,3.419642857142857,4.542790638465892,['LPL'],0.6153604688481805,0,0,1
34,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.28834437960623455,3.0770833333333334,3.826660066152266,['NDUFA13'],0.6153604688481805,0,0,1
35,Endothelin Pathways WP2197,0.29979099764398537,2.9302721088435373,3.530010085679594,['RIIAD1'],0.6153604688481805,0,0,1
36,CAMKK2  Pathway WP4874,0.29979099764398537,2.9302721088435373,3.530010085679594,['FIS1'],0.6153604688481805,0,0,1
37,Vitamin A and carotenoid metabolism WP716,0.29979099764398537,2.9302721088435373,3.530010085679594,['LPL'],0.6153604688481805,0,0,1
38,Development of ureteric collection system WP5053,0.29979099764398537,2.9302721088435373,3.530010085679594,['ANOS1'],0.6153604688481805,0,0,1
39,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3330441973499675,2.5632440476190474,2.818235752680591,['CYCS'],0.6198822081738304,0,0,1
40,Oxidative Damage WP3941,0.3330441973499675,2.5632440476190474,2.818235752680591,['CYCS'],0.6198822081738304,0,0,1
41,Parkinson's disease pathway WP2371,0.3330441973499675,2.5632440476190474,2.818235752680591,['CYCS'],0.6198822081738304,0,0,1
42,VEGFA-VEGFR2 Signaling Pathway WP3888,0.33378272747821636,1.2871932515337423,1.412392121442148,"['RPL18A', 'SSR4', 'CYCS', 'RPL26', 'RPL10A', 'TMSB10']",0.6198822081738304,0,0,6
43,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3647270884723842,2.2777777777777777,2.2973801235140026,['CYCS'],0.6615979744382783,0,0,1
44,Cytosolic DNA-sensing pathway WP4655,0.38501317732453705,2.120279146141215,2.0237592019137516,['POLR2K'],0.6825233598025884,0,0,1
45,IL-18 signaling pathway WP4754,0.39957826360703563,1.3287683106526826,1.2189398018173352,"['NRN1', 'COX17', 'CYCS']",0.686154440455088,0,0,3
46,PPAR signaling pathway WP3942,0.4046551828324878,1.9831029185867897,1.7941528228001296,['LPL'],0.686154440455088,0,0,1
47,Aryl Hydrocarbon Receptor Netpath WP2586,0.4236734367953512,1.8625541125541125,1.5995471613759404,['LPL'],0.6884693347924457,0,0,1
48,Rett syndrome causing genes WP4312,0.4236734367953512,1.8625541125541125,1.5995471613759404,['GPS2'],0.6884693347924457,0,0,1
49,IL-4 signaling pathway WP395,0.4510741937841512,1.7068452380952381,1.3588595084917707,['HRH1'],0.7034022356253775,0,0,1
50,Integrated breast cancer pathway WP1984,0.45805722130552273,1.3078099120907123,1.0210871909857906,"['PLK3', 'FAU']",0.7034022356253775,0,0,2
51,Exercise-induced Circadian Regulation WP410,0.45991684637043917,1.6605534105534105,1.289767733110776,['SUMO1'],0.7034022356253775,0,0,1
52,DNA damage response WP707,0.4856040829909062,1.5355654761904762,1.1092335820971788,['CYCS'],0.7194402703192755,0,0,1
53,miRNA regulation of DNA damage response WP1530,0.4938936522884479,1.4979674796747968,1.0567187845023494,['CYCS'],0.7194402703192755,0,0,1
54,Translation Factors WP107,0.502050411242572,1.4621598639455782,1.0075081900513227,['EEF1B2'],0.7194402703192755,0,0,1
55,AGE/RAGE pathway WP2324,0.517973926233948,1.3954274891774892,0.9179545863213596,['CYCS'],0.7194402703192755,0,0,1
56,MET in type 1 papillary renal cell carcinoma WP4205,0.517973926233948,1.3954274891774892,0.9179545863213596,['RPL11'],0.7194402703192755,0,0,1
57,Acute viral myocarditis WP4298,0.5257448129256244,1.3642857142857143,0.877152943747176,['CYCS'],0.7194402703192755,0,0,1
58,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5409149274566887,1.3059777102330294,0.8025145046224982,['LPL'],0.7222833410475117,0,0,1
59,Apoptosis WP254,0.5556025700365474,1.2524295432458699,0.7360554005488844,['CYCS'],0.7222833410475117,0,0,1
60,Retinoblastoma gene in cancer WP2446,0.5556025700365474,1.2524295432458699,0.7360554005488844,['H2AFZ'],0.7222833410475117,0,0,1
61,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5767626401993453,1.179830586080586,0.6492896371546145,['CYCS'],0.7258803297997348,0,0,1
62,Joubert Syndrome WP4656,0.5835909842202234,1.1574573225516622,0.6233543253482853,['ARL3'],0.7258803297997348,0,0,1
63,EGF/EGFR signaling pathway WP437,0.5862879586844012,1.0218562874251498,0.5456142512177228,"['NDUFA13', 'NEDD8']",0.7258803297997348,0,0,2
64,Non-small cell lung cancer WP4255,0.6034258255349567,1.0951318027210883,0.553186285489665,['CYCS'],0.7317917264380954,0,0,1
65,Apoptosis Modulation and Signaling WP1772,0.6098264386984129,1.0758145363408522,0.5320773098085101,['CYCS'],0.7317917264380954,0,0,1
66,22q11.2 copy number variation syndrome WP4657,0.6223211932957491,1.0391444713478613,0.4928651125279853,['MRPL40'],0.7354705011677035,0,0,1
67,Small cell lung cancer WP4658,0.640321333126555,0.9885752688172043,0.44069217016568984,['CYCS'],0.7411488735965186,0,0,1
68,"GPCRs, Class A Rhodopsin-like WP455",0.6461297872379906,0.9727891156462585,0.4248703996387344,['HRH1'],0.7411488735965186,0,0,1
69,Genes related to primary cilium development (based on CRISPR) WP4536,0.6738026480889295,0.9008228291316527,0.3556610839091558,['ARL3'],0.7616899500135724,0,0,1
70,Adipogenesis WP236,0.7228581130321003,0.7845695970695971,0.2546260400726681,['LPL'],0.8054704688071975,0,0,1
71,Mesodermal commitment pathway WP2857,0.7445608531762603,0.7369477911646586,0.21737063135296064,['RPL38'],0.8106328230760286,0,0,1
72,mRNA Processing WP411,0.7527611078006216,0.7194677871148459,0.2043341435389798,['SRSF9'],0.8106328230760286,0,0,1
73,DNA Repair Pathways Full Network WP4946,0.7606996190289179,0.7027914614121511,0.19222521382013202,['CENPX'],0.8106328230760286,0,0,1
74,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7758243748355972,0.6716378859236002,0.17048124380493854,['LPL'],0.8106328230760286,0,0,1
75,TGF-beta Signaling Pathway WP366,0.7794546375731044,0.6642727743271222,0.16551072686151483,['SUMO1'],0.8106328230760286,0,0,1
76,Hepatitis B infection WP4666,0.803281341448416,0.6168831168831169,0.13512840927029063,['CYCS'],0.8244203241181113,0,0,1
77,Circadian rhythm related genes WP3594,0.8157286976774956,0.5926953305594083,0.12071630730070007,['RPS27A'],0.8263225768681123,0,0,1
78,Ciliopathies WP4803,0.8627296901659351,0.5036402990948445,0.07436443325165468,['ARL3'],0.8627296901659351,0,0,1
